Published in Int J Cancer on September 15, 1978
Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis (2012) 1.35
The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis (2011) 0.98
African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg (2011) 0.97
Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women. J Infect Dis (2013) 0.87
Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection. Clin Diagn Lab Immunol (2004) 0.86
Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya. Matern Child Health J (2015) 0.83
Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants. J Infect Dis (2016) 0.82
Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLoS Pathog (2015) 0.81
Breast Milk as a Potential Source of Epstein-Barr Virus Transmission Among Infants Living in a Malaria-Endemic Region of Kenya. J Infect Dis (2015) 0.80
Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy. Clin Vaccine Immunol (2015) 0.79
Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations. Sci Rep (2015) 0.78
In vivo activation of toll-like receptor-9 induces an age-dependent abortive lytic cycle reactivation of murine gammaherpesvirus-68. Viral Immunol (2010) 0.78
Clinical features of Epstein-Barr virus-associated infectious mononucleosis in hospitalized Korean children. Korean J Pediatr (2011) 0.78
Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study. PLoS One (2016) 0.75
Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice. Oncotarget (2016) 0.75
Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases. J Virol (2017) 0.75
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants. Sci Rep (2017) 0.75
Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol (1966) 18.33
INTERFERENCE OF INACTIVE VIRUS WITH THE PROPAGATION OF VIRUS OF INFLUENZA. Science (1943) 10.31
Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A (1968) 8.67
Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science (1967) 8.62
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science (1970) 7.60
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07
THE DEMONSTRATION OF ONE-STEP GROWTH CURVES OF INFLUENZA VIRUSES THROUGH THE BLOCKING EFFECT OF IRRADIATED VIRUS ON FURTHER INFECTION. J Exp Med (1947) 5.91
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 4.51
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : I. THE DISPERSION OF THE VIRUS OF INFLUENZA A IN TISSUE EMULSIONS AND IN EXTRA-EMBRYONIC FLUIDS OF THE CHICK. J Exp Med (1943) 4.30
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst (1966) 4.19
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
HIV transmission through breastfeeding: a study in Malawi. JAMA (1999) 4.00
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69
NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES. Science (1944) 3.61
Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Hum Pathol (1974) 3.58
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A (1985) 3.35
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
THE EFFECT OF VITAMIN B(1) DEFICIENCY AND OF RESTRICTED FOOD INTAKE ON THE RESPONSE OF MICE TO THE LANSING STRAIN OF POLIOMYELITIS VIRUS. J Exp Med (1944) 3.17
SEROLOGICAL SPECIFICITY OF HEAVY PARTICLES DERIVED FROM NORMAL ORGANS. Science (1940) 3.12
Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol (1968) 3.09
Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA (2001) 3.07
Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07
Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer (1971) 3.00
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med (1997) 2.81
Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells. J Bacteriol (1966) 2.79
Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet (1982) 2.58
High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51
STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B. J Exp Med (1946) 2.50
Involvement of C group chromosomes in five Burkitt lymphoma cell lines. J Natl Cancer Inst (1967) 2.49
THE EFFECT OF ULTRAVIOLET IRRADIATION ON VARIOUS PROPERTIES OF INFLUENZA VIRUSES. J Exp Med (1947) 2.42
Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J Bacteriol (1966) 2.42
Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proc Natl Acad Sci U S A (1986) 2.34
Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28
Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25
The AIDS problem in Africa. Lancet (1986) 2.25
STUDIES ON THE NATURE OF THE VIRUS OF INFLUENZA : II. THE SIZE OF THE INFECTIOUS UNIT IN INFLUENZA A. J Exp Med (1943) 2.24
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun (2001) 2.19
Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma. J Bacteriol (1966) 2.15
Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res (1967) 2.05
Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ (1997) 2.03
Replication of mumps virus in human leukocyte cultures. J Bacteriol (1966) 2.03
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet (1990) 2.00
RELATION OF FOOD INTAKE TO RESPONSE OF MICE INOCULATED WITH LANSING STRAIN OF MURINE POLIOMYELITIS VIRUS. Science (1943) 1.94
Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) (1985) 1.93
Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet (1991) 1.92
STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : II. THE EFFECT OF INTRA-ABDOMINAL AND INTRAVENOUS INJECTION OF INFLUENZA VIRUSES. J Exp Med (1946) 1.91
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses. J Exp Med (1977) 1.90
Epstein-Barr virus RNA in Burkitt tumor tissue. Cell (1979) 1.88
Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J Infect Dis (1974) 1.87
STUDIES ON THE ANTIGENIC STRUCTURE OF SOME MAMMALIAN SPERMATOZOA. J Exp Med (1938) 1.86
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet (1985) 1.85
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83